Cargando…

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort

PURPOSE: The increase in clinical trials with androgen receptor (AR)-targeting drugs emphasizes the need of clarifying the role of AR expression in different breast cancer subtypes. AR confers good prognosis in estrogen receptor positive (ER+) breast cancer, but its role in ER-negative (ER−) breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elebro, Karin, Bendahl, Pär-Ola, Jernström, Helena, Borgquist, Signe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602002/ https://www.ncbi.nlm.nih.gov/pubmed/28643022 http://dx.doi.org/10.1007/s10549-017-4343-0

Ejemplares similares

Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
por: Bjarnadottir, Olöf, et al.
Publicado: (2020)

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
por: Godina, Christopher, et al.
Publicado: (2023)

Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort study
por: Godina, Christopher, et al.
Publicado: (2021)

CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
por: Kimbung, Siker, et al.
Publicado: (2020)

High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
por: Inasu, Maria, et al.
Publicado: (2021)

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
por: Persson, Mia, et al.
Publicado: (2016)

A novel model for Ki67 assessment in breast cancer
por: Romero, Quinci, et al.
Publicado: (2014)

The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial
por: Feldt, Maria, et al.
Publicado: (2020)

Vitamin D receptor expression in invasive breast tumors and breast cancer survival
por: Huss, Linnea, et al.
Publicado: (2019)

Adipocytes Under Obese-Like Conditions Change Cell Cycle Distribution and Phosphorylation Profiles of Breast Cancer Cells: The Adipokine Receptor CAP1 Matters
por: Bergqvist, Malin, et al.
Publicado: (2021)

Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
por: Harborg, Sixten, et al.
Publicado: (2020)

Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study
por: Bengtsson, Ylva, et al.
Publicado: (2021)

Postmenopausal overweight and breast cancer risk; results from the KARMA cohort
por: Klintman, Marie, et al.
Publicado: (2022)

Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events
por: Simonsson, Maria, et al.
Publicado: (2014)

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
por: Gustbée, Emma, et al.
Publicado: (2015)

Levels of Vitamin D and Expression of the Vitamin D Receptor in Relation to Breast Cancer Risk and Survival
por: Huss, Linnea, et al.
Publicado: (2022)

Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial
por: Feldt, Maria, et al.
Publicado: (2015)

Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer
por: Bergqvist, Malin, et al.
Publicado: (2020)

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer
por: Björner, Sofie, et al.
Publicado: (2017)

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
por: Björner, Sofie, et al.
Publicado: (2016)

The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study
por: Tryggvadottir, Helga, et al.
Publicado: (2021)

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
por: Lundgren, Christine, et al.
Publicado: (2019)

Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study
por: Inasu, Maria, et al.
Publicado: (2022)

Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study
por: Andersson, Gustav, et al.
Publicado: (2018)

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
por: Romero, Quinci, et al.
Publicado: (2011)

Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
por: Sandén, Emma, et al.
Publicado: (2020)

Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study
por: Harborg, Sixten, et al.
Publicado: (2021)

Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment
por: Godina, Christopher, et al.
Publicado: (2020)

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment
por: Björner, Sofie, et al.
Publicado: (2018)

Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2004)

Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients
por: Markkula, Andrea, et al.
Publicado: (2014)

Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study
por: Haque, Reina, et al.
Publicado: (2017)

St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial
por: Falck, Anna-Karin, et al.
Publicado: (2013)

Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
por: Nilsson, Linn, et al.
Publicado: (2020)

Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study
por: Johns, Louise E, et al.
Publicado: (2017)

The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer
por: Strand, Carina, et al.
Publicado: (2013)

Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
por: Scott, Oliver William, et al.
Publicado: (2023)

Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study
por: Rosendahl, Ann H., et al.
Publicado: (2021)

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients
por: Tryggvadottir, Helga, et al.
Publicado: (2018)

Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
por: Jansson, Sara, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_84c23pmv17fodgun74k12c3l32